The risk and risk factors of a second non-melanoma skin cancer: A study in a Mediterranean population

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 2, 2004, Pages 142-147

  Graells, J ^a,b  

^a Department of Dermatology   (Spain)

^b NONE   (Spain)

Author keywords

Basal cell carcinoma; Keratoacanthoma; Reoccurrence; Second primary (neo); Squamous cell carcinoma; Subsequent

Indexed keywords

AGE; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HISTOPATHOLOGY; HUMAN; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SECOND CANCER; SKIN CANCER; SOUTHERN EUROPE;

AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; KERATOACANTHOMA; MALE; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SKIN NEOPLASMS; SPAIN;

EID: 1642360832     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00893.x     Document Type: Article

References (25)

1. English DR, Kricker A, Heenan PJ et al. Incidence of non-melanocytic skin cancer in Geraldton, Western Australia. Int J Cancer 1997; 73: 629-633.
2. Roberts DL. Incidence of non-melanoma skin cancer in West Glamorgan, South Wales. Br J Dermatol 1990; 122: 399-403.
3. Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J 1988; 296: 13-17.
4. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol 1994; 30: 774-778.
5. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol 2000; 143: 1224-1229.
6. Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: Are primary prevention programs starting to have an effect? Int J Cancer 1998; 78: 144-148.
7. Plesko I, Severi G, Obsitnikova A, Boyle P. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-95. Neoplasma 2000; 47: 137-142.
8. Fears TR, Scotto J. Changes in skin cancer morbidity between 1971-72 and 1977-78. J Natl Cancer Inst 1982; 69: 365-370.
9. Bower CPR, Lear JT, De Berker DA. Basal cell carcinoma follow-up practices by dermatologists: A national survey. Br J Dermatol 2001; 145: 949-956.
10. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer. Arch Dermatol 2000; 136: 1524-1530.
11. Veien K, Veien NK. Risk of developing subsequent nonmelanoma skin cancers. Arch Dermatol 2001; 137: 1251.
12. Epstein E. Value of follow-up after treatment of basal cell carcinoma. Arch Dermatol 1973; 108: 798-800.
13. Robinson JK. Risk of developing another basal cell carcinoma. A 5-year prospective study. Cancer 1987; 60: 118-120.
14. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958; 8: 699-712.
15. Doménech Massons JM. Análisis de la supervivencia. Métodos de Kaplan-Meier y Actuarial. Comparación de curvas. In: Métodos Estadísticos en Ciencias de la Salud. Signo, Barcelona, 1995; 12: 3-44.
16. Bastiaens MT, Hoefnagel JJ, Gruijn JA et al. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 1998; 110: 880-884.
17. Greenberg ER, Baron JA, Stukel TA et al. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. N Engl J Med 1990; 323: 789-795.
18. Karagas MR, Stukel TA, Greenberg ER et al. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. J Am Med Assoc 1992; 267: 3305-3310.
19. Tangrea JA, Edwards BK, Taylor PR et al. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcino ma: A multicenter clinical trial. J Natl Cancer Inst 1992; 84: 328-332.
20. Bergstresser PR, Halprin KM. Multiple sequential skin cancers. Arch Dermatol 1975; 111: 995-996.
21. Frankel DH, Hanusa BH, Zitelli JA. New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. J Am Acad Dermatol 1992; 26: 720-726.
22. Marghoob A, Kopf AW, Bart RS et al. Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma. J Am Acad Dermatol 1993; 28: 22-28.
23. Schreiber MM, Moon TE, Fox SH, Davidson J. The risk of developing subsequent nonmelanoma skin cancers. J Am Acad Dermatol 1990; 23: 1114-1118.
24. Czarnecki D, Mar A, Staples M et al. The development of non-melanocytic skin cancers in people with a history of skin cancer. Dermatology 1994; 189: 364-367.
25. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: Implications for patient follow-up. J Dermatol Surg Oncol 1989; 15: 315-328.